My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 138

    1.

    Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes.

    Lamhamedi-Cherradi SE, Zheng S, Tisch RM, Chen YH.

    Diabetes. 2003 Sep;52(9):2274-8.PMID: 12941766 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice.

    Mi QS, Ly D, Lamhamedi-Cherradi SE, Salojin KV, Zhou L, Grattan M, Meagher C, Zucker P, Chen YH, Nagle J, Taub D, Delovitch TL.

    Diabetes. 2003 Aug;52(8):1967-75.PMID: 12882912 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.

    Hilliard B, Wilmen A, Seidel C, Liu TS, Göke R, Chen Y.

    J Immunol. 2001 Jan 15;166(2):1314-9.PMID: 11145715 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes.

    Vaccarezza M, Delbello G, Zauli G.

    Acta Biomed. 2007;78 Suppl 1:262-7.PMID: 17465340 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.

    Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH.

    Nat Immunol. 2003 Mar;4(3):255-60. Epub 2003 Feb 10.PMID: 12577054 [PubMed - indexed for MEDLINE]Related articles

    6.

    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

    Song K, Chen Y, Göke R, Wilmen A, Seidel C, Göke A, Hilliard B, Chen Y.

    J Exp Med. 2000 Apr 3;191(7):1095-104.PMID: 10748228 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.

    Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, Ben Gal Y, Keren G, George J.

    J Am Coll Cardiol. 2005 Apr 5;45(7):1018-24.PMID: 15808757 [PubMed - indexed for MEDLINE]Related articles

    8.

    Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.

    Ishikawa E, Nakazawa M, Yoshinari M, Minami M.

    J Virol. 2005 Jun;79(12):7658-63.PMID: 15919918 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

    Zheng SJ, Wang P, Tsabary G, Chen YH.

    J Clin Invest. 2004 Jan;113(1):58-64.PMID: 14702109 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

    Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

    J Immunol. 2000 Sep 1;165(5):2841-9.PMID: 10946317 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.

    Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.

    Hum Pathol. 2005 Oct;36(10):1066-73.PMID: 16226105 [PubMed - indexed for MEDLINE]Related articles

    12.

    Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.

    Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H, Mizusawa H, Koyanagi Y.

    J Exp Med. 2001 Mar 5;193(5):651-60.PMID: 11238596 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation embryo.

    Riley JK, Heeley JM, Wyman AH, Schlichting EL, Moley KH.

    Biol Reprod. 2004 Sep;71(3):871-7. Epub 2004 May 5.PMID: 15128592 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.

    Secchiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, Rimondi E, Fabris B, Giacca M, Zauli G.

    Circulation. 2006 Oct 3;114(14):1522-30. Epub 2006 Sep 25.PMID: 17000905 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.

    Song K, Benhaga N, Anderson RL, Khosravi-Far R.

    Cancer Res. 2006 Jun 15;66(12):6304-11.PMID: 16778207 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation.

    Xie L, Shi W, Guo P.

    Transplantation. 2003 Dec 15;76(11):1556-9.PMID: 14702523 [PubMed - indexed for MEDLINE]Related articles

    17.

    Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.

    Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM.

    Gastroenterology. 2006 Jun;130(7):1962-74.PMID: 16762619 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.

    Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T.

    Immunology. 2004 Feb;111(2):186-94.PMID: 15027904 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.

    Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, Kassahn D, Torgler R, Mueller C, Schneider P, Brunner T.

    J Clin Invest. 2006 Sep;116(9):2493-9.PMID: 16955144 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.

    Ou D, Wang X, Metzger DL, James RF, Pozzilli P, Plesner A, Korneluk RG, Verchere CB, Tingle AJ.

    Hum Immunol. 2005 Mar;66(3):274-84.PMID: 15784465 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity